Muscular Dystrophy Association
Anjan Aralihalli is an accomplished professional in the life sciences sector with extensive experience in executive leadership, business development, and venture capital. As the founder of Raya Therapeutic, Inc., Anjan focuses on developing disease-modifying therapies for neurodegenerative diseases. Anjan serves as a venture partner at CTI Life Sciences Fund and is a board member of the Muscular Dystrophy Association, contributing to innovations in care for neuromuscular diseases. Anjan has held key positions at several organizations, including Chief Business Officer at GLyPharma Therapeutic and Vice President of Business Development at Intrexon Corporation. Anjan's educational background includes a Master of Science in Biotechnology from The Johns Hopkins University and an MBA in Finance from Queen's University.
Muscular Dystrophy Association
If you’re seeking to start or advance your career with a purpose, Muscular Dystrophy Association is an employer that will enable you to thrive. The Muscular Dystrophy Association is the #1 voluntary health organization in the United States for people living with muscular dystrophy, ALS, and related neuromuscular diseases. For over 70 years, MDA has led the way in accelerating research, advancing care, and advocating for the support of our families. Our mission is to empower the people we serve to live longer, more independent lives. #MDA #MuscularDystrophy #ALS #neuromuscuar. Apply now.